SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Exagen Inc. – ‘8-K’ for 1/23/23 – ‘EX-3.1’

On:  Monday, 1/23/23, at 9:00am ET   ·   For:  1/23/23   ·   Accession #:  1274737-23-4   ·   File #:  1-39049

Previous ‘8-K’:  ‘8-K’ on / for 1/9/23   ·   Next:  ‘8-K’ on / for 3/20/23   ·   Latest:  ‘8-K’ on / for 5/13/24   ·   9 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 1/23/23  Exagen Inc.                       8-K:5,7,9   1/23/23   12:202K

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     40K 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML      9K 
 3: EX-99.1     Miscellaneous Exhibit                               HTML     14K 
 7: R1          Cover                                               HTML     49K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- exdx-20230123_htm                   XML     23K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 5: EX-101.LAB  XBRL Labels -- exdx-20230123_lab                     XML     72K 
 6: EX-101.PRE  XBRL Presentations -- exdx-20230123_pre              XML     35K 
 4: EX-101.SCH  XBRL Schema -- exdx-20230123                         XSD     10K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    18K 
12: ZIP         XBRL Zipped Folder -- 0001274737-23-000004-xbrl      Zip     23K 


‘EX-3.1’   —   Articles of Incorporation/Organization or Bylaws


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 3.1

AMENDMENT TO
THE AMENDED AND RESTATED BYLAWS OF
EXAGEN INC.
Pursuant to Article X of the Amended and Restated Bylaws (the “Bylaws”) of Exagen Inc. (the “Corporation”), the Bylaws are hereby amended as follows:
Section 3.3 of the Bylaws is hereby amended and restated in its entirety, as follows:
“3.3    ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS. 
Except as provided in Section 3.4 of these bylaws, each director, including, without limitation, a director elected to fill a vacancy, shall hold office until the expiration of the term for which elected and until such director’s successor is elected and qualified or until such director’s earlier death, resignation or removal. Directors need not be stockholders unless so required by the certificate of incorporation or these bylaws. The Board may appoint from its members, an executive chairperson of the Board, a chairperson of the Board and a vice chairperson of the Board. The executive chairperson of the Board, if any, shall also be the chairperson of the Board. Each of the executive chairperson of the Board, chairperson of the Board and vice chairperson of the Board, if any, shall perform such duties and possess such powers as are assigned by the Board. The certificate of incorporation or these bylaws may prescribe other qualifications for directors.”
Section 5.1 of the Bylaws is hereby amended and restated in its entirety, as follows:
“5.1    OFFICERS. 
The officers of the Corporation shall be a president and a secretary. The Corporation may also have, at the discretion of the Board, an executive chairperson, a chief executive officer, a chief financial officer or treasurer, one (1) or more vice presidents, one (1) or more assistant vice presidents, one (1) or more assistant treasurers, one (1) or more assistant secretaries, and any such other officers as may be appointed in accordance with the provisions of these bylaws. Any number of offices may be held by the same person.”
Section 5.3 of the Bylaws is hereby amended and restated in its entirety, as follows:
“5.3    SUBORDINATE OFFICERS. 
The Board may appoint, or empower the executive chairperson or chief executive officer or, in the absence of an executive chairperson and a chief executive officer, the president, to appoint, such other officers and agents as the business of the Corporation may require. Each of such officers shall hold office for such period, as is provided in these bylaws or as the Board may from time to time determine.”

Adopted: January 19, 2023
    


Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:1/23/23None on these Dates
1/19/23
 List all Filings 


9 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/13/24  Exagen Inc.                       10-Q        3/31/24   58:4.7M
 3/18/24  Exagen Inc.                       10-K       12/31/23   76:8.9M
11/29/23  Exagen Inc.                       424B5                  1:426K                                   Workiva Inc Wde… FA01/FA
11/27/23  Exagen Inc.                       S-3/A                  3:611K
11/17/23  Exagen Inc.                       S-3                    4:683K                                   Workiva Inc Wde… FA01/FA
11/13/23  Exagen Inc.                       10-Q        9/30/23   59:169M
 8/07/23  Exagen Inc.                       10-Q        6/30/23   55:4.9M
 5/18/23  Exagen Inc.                       S-8         5/18/23    4:132K
 3/20/23  Exagen Inc.                       10-K       12/31/22   76:9.1M
Top
Filing Submission 0001274737-23-000004   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 8:20:24.2pm ET